See every side of every news story
Published loading...Updated

Hydrogel embolic system demonstrates positive safety and efficacy in “first” peripheral application trial - Interventional News

Summary by Interventional News
Abi-Jaoudeh presenting at SIR 2025 Preliminary results from the prospective, randomised, multicentre Instylla Hydrogel Embolic System (HES; Instylla) trial show the liquid embolic met primary safety and effectiveness endpoints, with a 99% freedom from major adverse event rate at 30 days follow-up, compared to a literature-derived performance goal of 75%.  The results of the trial were presented by Nadine Abi-Jaoudeh (University of California, Ir…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Interventional News broke the news in on Friday, April 4, 2025.
Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.